FOXO TECHNOLOGIES INC. FOXO revenue by segment, product and geography
In its fiscal year ending 2025-12-31, FOXO TECHNOLOGIES INC. reported revenue across 4 business segments; the largest, Health Cares, was $16.1M, 98.3% of the filed sum (+300.3% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Health Cares$16.1M98.3%+300.3% yoy
- Life Science Services$253K1.5%no prior
- Corporate And Other$15.1K0.1%no prior
- Labs$13.9K0.1%-57.3% yoy
Members sum to the consolidated $16.4M for this period.
- Health Cares$4.8M92.9%+51.8% yoy
- Life Science Services$361K7.0%no prior
- Labs$4.39K0.1%-48.3% yoy
- Corporate And Other$3.85K0.1%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.